Study/Author | MBG 0-1 | MBG 3 | ST segment resolution | Post procedural TIMI 3 flow | ||||
---|---|---|---|---|---|---|---|---|
 | Thrombectomy | Control | Thrombectomy | Control | Thrombectomy | Control | Thrombectomy | Control |
Svilaas | 17% | 26% | 46% | 32% | 57% | 44% | 86% | 83% |
 | 84 | 129 | 224 | 158 | 275 | 219 | 431 | 409 |
AIMI | 45% | 36% | 27% | 32% | 60% | 68% | 91% | 97% |
 | 105 | 85 | 63 | 75 | 105 | 111 | 213 | 228 |
DEAR-MI | 0% | 7% | 88% | 43% | 68% | 50% | 89% | 78% |
 | 0 | 5 | 65 | 32 | 50 | 37 | 66 | 58 |
Kaltoft | N/A | N/A | N/A | N/A | 23% | 22% | 89% | 88% |
 |  |  |  |  | 22 | 20 | 93 | 91 |
De Luca | N/A | N/A | 37% | 13% | 82% | 55% | 79% | 68% |
 |  |  | 14 | 5 | 31 | 21 | 30 | 26 |
X-AMINE ST | 25% | 25% | 31% | 30% | 68% | 53% | 96% | 89% |
 | 23 | 23 | 29 | 28 | 61 | 50 | 96 | 90 |
REMEDIA | 32% | 55% | N/A | N/A | 63% | 37% | 77% | 63% |
 | 16 | 27 |  |  | 29 | 18 | 37 | 31 |
VAMPIRE | 17% | 37% | 46% | 20% | N/A | N/A | 88% | 81% |
 | 30 | 63 | 82 | 35 |  |  | 155 | 137 |
EXPORT | N/A | N/A | 63% | 42% | 50% | 12% | 96% | 81% |
 |  |  | 15 | 11 | 12 | 3 | 23 | 21 |
Dudek | N/A | N/A | 55% | 38% | 68% | 25% | 85% | 86% |
 |  |  | 22 | 12 | 27 | 8 | 34 | 27 |
Antoniucci | N/A | N/A | N/A | N/A | 90% | 72% | 100% | 100% |
 |  |  |  |  | 45 | 36 | 50 | 50 |
NON STOP | N/A | N/A | N/A | N/A | N/A | N/A | 94% | 91% |
 |  |  |  |  |  |  | 130 | 119 |
Napodano | 15% | 46% | 72% | 37% | 83% | 52% | 94% | 96% |
 | 7 | 21 | 33 | 17 | 38 | 24 | 43 | 44 |
Beran | N/A | N/A | N/A | N/A | 83% | 52% | 90% | 84% |
 |  |  |  |  | 19 | 12 | 27 | 26 |
Chevalier | 28% | 32% | 36% | 25% | 74% | 65% | 82% | 77% |
 | 33 | 41 | 43 | 33 | 88 | 84 | 98 | 99 |
EXPIRA | 12% | 40% | 70% | 29% | 80% | 38% | N/A | N/A |
 | 10 | 34 | 62 | 25 | 70 | 33 |  |  |
PIHRATE | N/A | N/A | 76% | 59% | 50% | 41% | 88% | 82% |
 |  |  | 78 | 55 | 51 | 39 | 90 | 77 |